LSB
vs
AMGN
LSB
AMGN
Over the past 12 months, LSB has underperformed AMGN, delivering a return of -75% compared to the AMGN's +26% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
LSB
AMGN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
YS Biopharma Co Ltd
NASDAQ:LSB
|
0.627
USD
|
|||||
|
Amgen Inc
NASDAQ:AMGN
|
365.765
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
LSB, AMGN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
YS Biopharma Co Ltd
Revenue
|
|||||||||||
|
Amgen Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
LSB, AMGN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
YS Biopharma Co Ltd
NASDAQ:LSB
|
|||||||||
|
Amgen Inc
NASDAQ:AMGN
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
LSB, AMGN
Performance By Year
LSB, AMGN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.